Amphastar Pharmaceuticals Statistics
Total Valuation
AMPH has a market cap or net worth of $1.35 billion. The enterprise value is $1.78 billion.
| Market Cap | 1.35B |
| Enterprise Value | 1.78B |
Important Dates
The next estimated earnings date is Wednesday, May 7, 2025, after market close.
| Earnings Date | May 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AMPH has 47.65 million shares outstanding. The number of shares has decreased by -1.78% in one year.
| Current Share Class | 47.65M |
| Shares Outstanding | 47.65M |
| Shares Change (YoY) | -1.78% |
| Shares Change (QoQ) | -1.06% |
| Owned by Insiders (%) | 8.61% |
| Owned by Institutions (%) | 74.35% |
| Float | 36.70M |
Valuation Ratios
The trailing PE ratio is 9.19 and the forward PE ratio is 8.91. AMPH's PEG ratio is 2.76.
| PE Ratio | 9.19 |
| Forward PE | 8.91 |
| PS Ratio | 1.88 |
| Forward PS | 1.77 |
| PB Ratio | 1.85 |
| P/TBV Ratio | 9.56 |
| P/FCF Ratio | 7.86 |
| P/OCF Ratio | 6.35 |
| PEG Ratio | 2.76 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.90, with an EV/FCF ratio of 10.35.
| EV / Earnings | 11.18 |
| EV / Sales | 2.44 |
| EV / EBITDA | 6.90 |
| EV / EBIT | 8.68 |
| EV / FCF | 10.35 |
Financial Position
The company has a current ratio of 3.07, with a Debt / Equity ratio of 0.89.
| Current Ratio | 3.07 |
| Quick Ratio | 2.10 |
| Debt / Equity | 0.89 |
| Debt / EBITDA | 2.46 |
| Debt / FCF | 3.77 |
| Interest Coverage | 5.81 |
Financial Efficiency
Return on equity (ROE) is 23.26% and return on invested capital (ROIC) is 9.70%.
| Return on Equity (ROE) | 23.26% |
| Return on Assets (ROA) | 8.31% |
| Return on Invested Capital (ROIC) | 9.70% |
| Return on Capital Employed (ROCE) | 14.63% |
| Revenue Per Employee | $360,930 |
| Profits Per Employee | $78,658 |
| Employee Count | 2,028 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 2.76 |
Taxes
In the past 12 months, AMPH has paid $29.67 million in taxes.
| Income Tax | 29.67M |
| Effective Tax Rate | 15.68% |
Stock Price Statistics
The stock price has decreased by -34.67% in the last 52 weeks. The beta is 0.77, so AMPH's price volatility has been lower than the market average.
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -34.67% |
| 50-Day Moving Average | 31.17 |
| 200-Day Moving Average | 40.74 |
| Relative Strength Index (RSI) | 43.73 |
| Average Volume (20 Days) | 628,207 |
Short Selling Information
The latest short interest is 3.85 million, so 8.09% of the outstanding shares have been sold short.
| Short Interest | 3.85M |
| Short Previous Month | 4.13M |
| Short % of Shares Out | 8.09% |
| Short % of Float | 10.50% |
| Short Ratio (days to cover) | 5.63 |
Income Statement
In the last 12 months, AMPH had revenue of $731.97 million and earned $159.52 million in profits. Earnings per share was $3.06.
| Revenue | 731.97M |
| Gross Profit | 373.86M |
| Operating Income | 205.42M |
| Pretax Income | 201.63M |
| Net Income | 159.52M |
| EBITDA | 258.39M |
| EBIT | 205.42M |
| Earnings Per Share (EPS) | $3.06 |
Balance Sheet
The company has $221.65 million in cash and $650.55 million in debt, giving a net cash position of -$428.90 million or -$9.00 per share.
| Cash & Cash Equivalents | 221.65M |
| Total Debt | 650.55M |
| Net Cash | -428.90M |
| Net Cash Per Share | -$9.00 |
| Equity (Book Value) | 732.30M |
| Book Value Per Share | 15.38 |
| Working Capital | 360.31M |
Cash Flow
In the last 12 months, operating cash flow was $213.39 million and capital expenditures -$41.04 million, giving a free cash flow of $172.35 million.
| Operating Cash Flow | 213.39M |
| Capital Expenditures | -41.04M |
| Free Cash Flow | 172.35M |
| FCF Per Share | $3.62 |
Margins
Gross margin is 51.08%, with operating and profit margins of 28.06% and 21.79%.
| Gross Margin | 51.08% |
| Operating Margin | 28.06% |
| Pretax Margin | 25.85% |
| Profit Margin | 21.79% |
| EBITDA Margin | 35.30% |
| EBIT Margin | 28.06% |
| FCF Margin | 23.55% |
Dividends & Yields
AMPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.78% |
| Shareholder Yield | n/a |
| Earnings Yield | 11.78% |
| FCF Yield | 12.72% |
Analyst Forecast
The average price target for AMPH is $43.50, which is 53.66% higher than the current price. The consensus rating is "Hold".
| Price Target | $43.50 |
| Price Target Difference | 53.66% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 3.88% |
| EPS Growth Forecast (5Y) | 4.34% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AMPH has an Altman Z-Score of 3.24 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.24 |
| Piotroski F-Score | 5 |